2024-10-05 - Analysis Report
## Cigna Group (CI) Stock Analysis Report

**Company Overview:** Cigna is a global health service company offering health insurance, pharmacy, and other related services.

**Performance Analysis:**

**1. Return vs S&P 500 (VOO):**

* **Cumulative Return (CI):** 149.29%
* **Cumulative Return (VOO):** 131.45%
* **Difference:** 17.84%
* **Relative Divergence:** 45.18% 

Cigna has outperformed the S&P 500 by 17.84%, placing its historical performance within the 45.18th percentile of its past performance relative to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $340.71
* **5-Day Moving Average:** $346.03
* **20-Day Moving Average:** $354.32
* **60-Day Moving Average:** $346.21

The stock is currently trading below its 5-day, 20-day, and 60-day moving averages, indicating a potential short-term downtrend.

**3. Technical Indicators:**

* **RSI:** 26.79 - This suggests that the stock is oversold, potentially indicating a buying opportunity.
* **PPO:** -0.63 -  A negative PPO value indicates that the stock's price is currently decreasing relative to its moving average.
* **Delta_Previous_Relative_Divergence:** -18.44 -  The negative value indicates a recent short-term downward trend in the stock's price.
* **Expected_Return:** 7.6% - The expected return represents a potential 5-year over-performance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | 60.52 B$ |
| 2024-05-02 | -0.97 | 57.26 B$ |
| 2023-11-02 | 4.79 | 49.05 B$ |
| 2023-08-03 | 4.96 | 48.59 B$ |
| 2024-08-01 | 4.96 | 48.59 B$ |

The most recent earnings report (2024-08-01) showed a positive EPS of 5.51, exceeding analyst expectations. The company's revenue also exceeded expectations, demonstrating strong growth.

**5. News and Recent Issues:**

Recent market outlook for Cigna is positive, with analysts citing strong earnings reports, a robust healthcare market, and the company's commitment to digital innovation as key drivers.

**Analyst Opinions:** According to FINBOLD, several analysts have recently raised their price targets for Cigna, citing its growth potential and attractive valuation.

**Performance Highlights:** Cigna has consistently shown strong financial performance in recent quarters, with revenue and earnings growth exceeding expectations. The company's focus on expanding its product offerings and leveraging technology for better customer experience is driving positive momentum.

**6. Overall Analysis:**

Cigna is a financially strong company with a positive market outlook. While the stock is currently experiencing some short-term price weakness, its fundamentals remain solid, and its long-term growth potential is supported by its leadership position in the healthcare industry. The technical indicators suggest a potential buying opportunity, and the expected return of 7.6% could make it an attractive investment option for investors with a long-term investment horizon. However, it's important to monitor its future performance and market trends closely.

**7. Summary:**

Cigna (CI) is a health services company with a strong track record of performance.  The company is currently trading below its moving averages, indicating potential short-term weakness, but with a recent strong earnings report, positive analyst sentiment, and expected returns exceeding the S&P 500, CI may present a valuable investment opportunity for long-term investors.  However, it is important to consider both the technical indicators and the broader market conditions before making any investment decisions. 
